HBAN Huntington Bancshares (HBAN) Insider Trading, Ownership & Congress Trades
Banks · National commercial banks · CIK 0000049196
Form 144 · 1
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
578
13F, latest reported quarter
What the filings say about HBAN
Insiders, 180 days
-$4.5M net sold
1 buyer · 4 sellers · 0% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: sale, 2025-04-08
Planned sales (Form 144), 90 days
$481.1K
1 notice
Huntington Bancshares insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, HUNTINGTON BANCSHARES INC /MD/ insiders sold a net $4.5M of stock across 118 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 7 earlier Form 4 trades (code P or S) here by this insider (7 sales), the last on Dec 12, 2025.
- The trade is 0.4% of the 97,595 shares held after it.
- No other insider sold within 30 days.
- 578 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Information Officer Kowalski Kendall A sold about $6.9K of HBAN on Aug 3, 2026; 578 funds added in the latest 13F quarter.Context
- 7 earlier Form 4 trades (code P or S) here by this insider (7 sales), the last on Dec 12, 2025.
- The trade is 39.4% of the 70,025 shares held after it.
- No other insider sold within 30 days.
- 578 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Information Officer Kowalski Kendall A sold about $474.2K of HBAN on Aug 3, 2026; 578 funds added in the latest 13F quarter.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Dec 11, 2025.
- The trade is 3.9% of the 267,859 shares held after it.
- 2 other insiders sold within 30 days.
- 578 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SEVP and General Counsel Hingst Marcy C sold about $190.2K of HBAN on Jun 25, 2026; 2 other insiders sold within 30 days and 578 funds added in the latest 13F quarter.Context
- 14 earlier Form 4 trades (code P or S) here by this insider (14 buys), the last on Jun 4, 2026.
- +2.6% median (+0.9% mean) 90-day return after 10 previous buys.
- The trade is 36.5% of the 612,155 shares held after it.
- 2 other insiders sold within 30 days.
- 578 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director ROLLINS JAMES D III sold about $3.9M of HBAN on Jun 12, 2026, the largest insider sale at the company on our record; 2 other insiders sold within 30 days and 578 funds added in the latest 13F quarter.Context
- 13 earlier Form 4 trades (code P or S) here by this insider (13 buys), the last on Jun 3, 2026.
- +2.7% median (+0.8% mean) 90-day return after 9 previous buys.
- The trade is 48.0% of the 10,000 shares held after it.
- No other insider bought within 30 days.
- 578 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director ROLLINS JAMES D III bought about $97.4K of HBAN on Jun 4, 2026; 578 funds added in the latest 13F quarter.118 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$4.5M over 180 days
-$481.1K over 90 days
below 88% of Banks
Congress
no House purchase disclosed in the last 12 months
Funds
578 funds bought in last quarter
more than 96% of Banks
Revenue
+6.4% year over year
more than 50% of Banks
Margin
141.5% net margin
below 56% of Banks
Buybacks
$150.0M repurchased, FY to 2026-03-31
more than 88% of Banks
Short interest
2.7% of the float short (float per yahoo 2026-10-26) · 1.4 days to cover · settled 2026-09-30
below 51% of Banks
What changed in the last 30 days
Oct 28Insider buying stopped: no purchases in 90 days after 4 in the prior 90
Why it matters
The absence is the signal: 4 purchases in one 90-day window and none in the next is a change of behaviour, not a filing.
Watch HBAN
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+2.0%12M
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns HBAN: institutional holders (13F)
13F holdings, latest reported quarter
176,786,560 sh
$3.1B
132,307,320 sh
$2.3B
122,300,772 sh
$2.2B
97,045,959 sh
$1.7B
94,335,667 sh
$1.7B
Congress trades in HBAN
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Sold 2025-04-08 · disclosed 30 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
HBAN planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Kowalski Kendall A
Filed 2026-08-03
$481.1K
Marcy Hingst
Filed 2026-06-25
$190.2K
HBAN mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
ICON CONSUMER SELECT
$1.3M position · as of 2026-06-30
4.9%
iShares U.S. Regional Banks ETF
$29.5M position · as of 2026-06-30
4.5%
Invesco Comstock Select Fund
$36.8M position · as of 2026-07-31
4.3%
Invesco KBW Bank ETF
$194.1M position · as of 2026-05-31
3.6%
Select Banking Portfolio
$16.4M position · as of 2026-05-31
3.6%
CresAlta Global Dividend ETF
$4.5M position · as of 2026-07-31
3.3%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Corporate PAC
The company's PAC: committee totals only, never individual donors (FEC).
Huntington Bancshares Inc. Political Action Committee (Hbi-Pac)
Cycle 2026 · $589K spent
$1.0M
Federal Election Commission, matched by the PAC's connected organisation
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$12.1M
$18.3M
$4.2M
+72%
+96%
2024
$10.0M
$19.8M
$4.2M
+55%
+48%
2023
$10.2M
$6.3M
$4.2M
+16%
+8%
2022
$10.5M
$9.9M
$4.8M
+22%
+9%
2021
$9.6M
$21.6M
$5.0M
+27%
+38%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $4.5M sold by insiders over 180 days, 578 funds added last quarter, $481.1K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
HBAN financials
Revenue growth
+6.4%
XBRL, annual
Net margin
141.5%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.7B
four quarters, 2025-04-01 to 2026-03-31
Revenue, TTM HBAN
| FY Dec 2025 | $1.6B |
| FY Dec 2024 | $1.5B |
| FY Dec 2023 | $1.4B |
| FY Dec 2022 | $1.3B |
| FY Dec 2021 | $1.1B |
| Mar 2026 | $472.0M |
| Dec 2025 | $410.0M |
| Sep 2025 | $424.0M |
| Jun 2025 | $377.0M |
| Mar 2025 | $351.0M |
| Dec 2024 | $410.0M |
| Sep 2024 | $362.0M |
| Jun 2024 | $360.0M |
At each fiscal year end
Single quarter
Net margin, TTM
+131.1%
net income over revenue, 2025-04-01 to 2026-03-31
Net margin, TTM HBAN
| FY Dec 2025 | +141.5% |
| FY Dec 2024 | +132.2% |
| FY Dec 2023 | +139.4% |
| FY Dec 2022 | +169.8% |
| FY Dec 2021 | +116.4% |
| Mar 2026 | +110.8% |
| Dec 2025 | +126.6% |
| Sep 2025 | +148.3% |
| Jun 2025 | +142.2% |
| Mar 2025 | +150.1% |
| Dec 2024 | +129.3% |
| Sep 2024 | +142.8% |
| Jun 2024 | +131.7% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$2.2B
operating cash flow minus capex, 2025-04-01 to 2026-03-31
Free cash flow, TTM HBAN
| FY Dec 2025 | $2.2B |
| FY Dec 2024 | $1.7B |
| FY Dec 2023 | $2.5B |
| FY Dec 2022 | $3.8B |
| FY Dec 2021 | $1.8B |
| Mar 2026 | $400.0M |
| Dec 2025 | $810.0M |
| Sep 2025 | $446.0M |
| Jun 2025 | $500.0M |
| Mar 2025 | $459.0M |
| Dec 2024 | $1.1B |
| Sep 2024 | -$100.0M |
| Jun 2024 | $255.0M |
At each fiscal year end
Single quarter
Debt to equity
0.72x
long-term 2026-03-31 plus current 2026-03-31; equity 2026-03-31
Debt to equity HBAN
| FY Dec 2025 | 0.76x |
| FY Dec 2024 | 0.84x |
| FY Dec 2023 | 0.67x |
| FY Dec 2022 | 0.66x |
| FY Dec 2021 | 0.39x |
| Mar 2026 | 0.72x |
| Dec 2025 | 0.76x |
| Sep 2025 | 0.79x |
| Jun 2025 | 0.86x |
| Mar 2025 | 0.92x |
| Dec 2024 | 0.84x |
| Sep 2024 | 0.80x |
| Jun 2024 | 0.85x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.11x
TTM operating cash flow over long-term 2026-03-31 plus current 2026-03-31
Cash flow to debt HBAN
| FY Dec 2025 | 0.13x |
| FY Dec 2024 | 0.11x |
| FY Dec 2023 | 0.20x |
| FY Dec 2022 | 0.34x |
| FY Dec 2021 | 0.28x |
| Mar 2026 | 0.11x |
| Dec 2025 | 0.13x |
| Sep 2025 | 0.15x |
| Jun 2025 | 0.12x |
| Mar 2025 | 0.10x |
| Dec 2024 | 0.11x |
| Sep 2024 | 0.10x |
| Jun 2024 | 0.16x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+8.3%
TTM net income over average of 2025-03-31 and 2026-03-31
Return on equity HBAN
| FY Dec 2025 | +10.0% |
| FY Dec 2024 | +9.9% |
| FY Dec 2023 | +10.5% |
| FY Dec 2022 | +12.1% |
| FY Dec 2021 | +8.0% |
| Mar 2026 | +8.3% |
| Dec 2025 | +10.0% |
| Sep 2025 | +10.4% |
| Jun 2025 | +10.4% |
| Mar 2025 | +10.3% |
| Dec 2024 | +9.9% |
| Sep 2024 | +8.5% |
| Jun 2024 | +8.8% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+0.9%
TTM net income over average of 2025-03-31 and 2026-03-31
Return on assets HBAN
| FY Dec 2025 | +1.0% |
| FY Dec 2024 | +1.0% |
| FY Dec 2023 | +1.0% |
| FY Dec 2022 | +1.3% |
| FY Dec 2021 | +0.9% |
| Mar 2026 | +0.9% |
| Dec 2025 | +1.0% |
| Sep 2025 | +1.1% |
| Jun 2025 | +1.0% |
| Mar 2025 | +1.0% |
| Dec 2024 | +1.0% |
| Sep 2024 | +0.9% |
| Jun 2024 | +0.9% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital HBAN
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed HBAN
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
12.10x
close 2026-10-26 over four quarters of diluted EPS, 2025-04-01 to 2026-03-31
P/E, trailing HBAN
| FY Dec 2025 | 12.48x |
| FY Dec 2024 | 13.23x |
| FY Dec 2023 | 10.26x |
| FY Dec 2022 | 9.72x |
| FY Dec 2021 | 16.76x |
| Mar 2026 | 12.04x |
| Dec 2025 | 12.48x |
| Sep 2025 | 12.08x |
| Jun 2025 | 12.41x |
| Mar 2025 | 11.46x |
| Dec 2024 | 13.23x |
| Sep 2024 | 14.13x |
| Jun 2024 | 12.43x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$53.7B
market value at close 2026-10-26 on 2026-03-31 shares, plus long-term 2026-03-31 plus current 2026-03-31, minus cash 2019-09-30
Enterprise value HBAN
| FY Dec 2025 | $42.2B |
| FY Dec 2024 | $38.6B |
| FY Dec 2023 | $29.8B |
| FY Dec 2022 | $30.4B |
| FY Dec 2021 | $28.1B |
| Mar 2026 | $53.6B |
| Dec 2025 | $42.2B |
| Sep 2025 | $41.1B |
| Jun 2025 | $40.9B |
| Mar 2025 | $39.0B |
| Dec 2024 | $38.6B |
| Sep 2024 | $36.2B |
| Jun 2024 | $34.2B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+6.8%
TTM free cash flow over market value at close 2026-10-26
FCF yield HBAN
| FY Dec 2025 | +8.7% |
| FY Dec 2024 | +7.2% |
| FY Dec 2023 | +13.7% |
| FY Dec 2022 | +18.7% |
| FY Dec 2021 | +8.1% |
| Mar 2026 | +6.8% |
| Dec 2025 | +8.7% |
| Sep 2025 | +9.9% |
| Jun 2025 | +8.0% |
| Mar 2025 | +7.8% |
| Dec 2024 | +7.2% |
| Sep 2024 | +6.8% |
| Jun 2024 | +13.2% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -1%, PEG needs growth
PEG, trailing HBAN
| FY Dec 2025 | 0.96x |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | 0.17x |
| FY Dec 2021 | 0.53x |
| Mar 2026 | n/a |
| Dec 2025 | 0.96x |
| Sep 2025 | 0.32x |
| Jun 2025 | 0.45x |
| Mar 2025 | 0.64x |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $1.6B | $1.5B | $1.4B | $1.3B |
| Net income | $2.2B | $1.9B | $2.0B | $2.2B |
| EPS (diluted) | 1.39 | 1.22 | 1.24 | 1.45 |
| Operating cash flow | $2.5B | $1.8B | $2.7B | $4.0B |
| Long-term debt | $17.2B | $16.4B | $12.4B | $9.7B |
| Buybacks | n/a | n/a | $0 | $0 |
| Dividends paid | $908.0M | $903.0M | $900.0M | $897.0M |
SEC XBRL, fiscal years, as known on 2026-10-28
HBAN Stock Sonar score 6/7 axes
Find similar shapesCompareHBAN ranks highest on institutional and government (82nd percentile) and growth (50th), and lowest on financial health (15th), among Banks peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
HBAN filings, in plain words
Are Huntington Bancshares insiders buying or selling HBAN?
In the 180 days to 2026-10-28, Huntington Bancshares insiders were net sellers, a net $4.5M: $401.2K of purchases and $4.9M of sales reported on Form 4, by 1 buyer and 4 sellers.
Have members of Congress traded HBAN?
Yes, but not in the year to 2026-10-28; the latest on record is a sale by Rob Bresnahan dated 2025-04-08.
Are there planned insider sales of HBAN?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $481.1K of stock; the latest, by Kowalski Kendall A, was filed 2026-08-03.
Read the full summary
In the 180 days to 2026-10-28, Huntington Bancshares insiders were net sellers of HBAN, a net $4.5M across purchases and sales reported on Form 4 by 1 buyer and 4 sellers. Sales outweighed purchases more than tenfold by value. None of the 5 insider sales was flagged as made under a Rule 10b5-1 plan. Members of Congress have disclosed trades in HBAN, none in the last year; the latest on record is a sale by Rob Bresnahan dated 2025-04-08. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $481.1K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
